GGrantIndex
← Leaderboards

Microgen, Llc

La Marque, TX

Compare ↔
$7,309,586
Total funding
11
Grants

Funding over time

peak $1.7M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,009,785 · 10
CDC$299,801 · 1

By mechanism

R44$2,977,159 · 1
R01$2,510,937 · 1
R43$1,126,697 · 4
R03$694,793 · 5

Investigators at Microgen, Llc

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

Not enough data

Largest grants

Development of a High Throughput Assay for Rapid Screening of Congenital Cytomegalovirus Infection using Dried Blood Spots$1,034,453
R44 · FY2023 · DC
Development of a High Throughput Assay for Rapid Screening of Congenital Cytomegalovirus Infection using Dried Blood Spots$998,523
R44 · FY2024 · DC
Development of a High Throughput Assay for Rapid Screening of Congenital Cytomegalovirus Infection using Dried Blood Spots$944,183
R44 · FY2025 · DC
Reductions in biopsychosocial risks for pregnant Latinas and their infants: the Mastery Lifestyle Intervention$643,393
R01 · FY2021 · HD
Reductions in biopsychosocial risks for pregnant Latinas and their infants: the Mastery Lifestyle Intervention$627,249
R01 · FY2023 · HD
Reductions in biopsychosocial risks for pregnant Latinas and their infants: the Mastery Lifestyle Intervention$625,951
R01 · FY2022 · HD
Reductions in biopsychosocial risks for pregnant Latinas and their infants: the Mastery Lifestyle Intervention$614,344
R01 · FY2024 · HD
PA21259, SBIR, Phase I, Development of a High Throughput Assay for Rapid Detection of HSV and Treponema pallidum$299,801
R43 · FY2022 · PS
Development of a High Throughput Assay for Rapid Screening of Congenital Cytomegalovirus Infection using Dried Blood Spots$291,613
R43 · FY2022 · DC
Low Cost Point-Of-Care Test For CMV$223,447
R43 · FY2017 · AI
Rapid User Friendly POC Diagnostic for HSV$189,631
R43 · FY2020 · AI
Low Cost Point-Of-Care Test For CMV$122,205
R43 · FY2019 · AI
The Impact of Maternal CMV Infection on Birth Outcomes$89,515
R03 · FY2022 · AI
The Impact of Maternal CMV Infection on Birth Outcomes$89,515
R03 · FY2021 · AI
Cytometric Enumeration of EBV-Infected Cells$87,475
R03 · FY2018 · AI
Cytometric Enumeration of EBV-Infected Cells$87,475
R03 · FY2019 · AI
Rapid FISH Detection of EBV-infected Cells$77,500
R03 · FY2009 · AI
3-D Oral Mucosa Model for EBV Pathogenesis$77,500
R03 · FY2010 · AI
Rapid FISH Detection of EBV-infected Cells$76,725
R03 · FY2010 · AI
3-D Oral Mucosa Model for EBV Pathogenesis$76,725
R03 · FY2011 · AI